• Search History (Register)
  • MeSH Browser
  • [Clear]
    • Canada

Welcome to the international HTA database


Showing [3276 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2016     Technology Assessment Unit of the McGill University Health Centre (MUHC) A mini-health technology assessment of Linear and Radial Endobronchial Ultrasound (EBUS) and Electromagnetic Navigation Bronchoscopy (ENB) in the diagnosis and staging of lung cancer in adults
2016     Technology Assessment Unit of the McGill University Health Centre (MUHC) Radiofrequency ablation for the treatment of Barrett's esophagus with high-grade and lowgrade dysplasia: an update
2016     Institut national d'excellence en sante et en services sociaux (INESSS) [Use of radioactive seeds for the preoperative localization of non-palpable breast tumours]
2016     Institut national d'excellence en sante et en services sociaux (INESSS) [Evaluation of subcutaneous-lead implantable cardioverter-defibrillators]
2016     Institut national d'excellence en sante et en services sociaux (INESSS) [Economic evaluation of the molecular diagnosis of the influenza virus]
2016     Institut national d'excellence en sante et en services sociaux (INESSS) [Clinical guides in antibiotic treatment – 1st series (update)]
2016     Institut national d'excellence en sante et en services sociaux (INESSS) [Standards regarding reperfusion treatments for ST-segment elevation acute myocardial infarction (STEMI) in Quebec]
2016     Institut national d'excellence en sante et en services sociaux (INESSS) [Clinical practice guidelines for the rehabilitation of adults having sustained a moderate to severe traumatic brain injury: development process and recommendations]
2016     Institut national d'excellence en sante et en services sociaux (INESSS) [Circulating tumour cells in breast cancer: clinical use of the CellSearch® test]
2016     Institut national d'excellence en sante et en services sociaux (INESSS) [Standards regarding reperfusion treatments for ST-segment elevation acute myocardial infarction (STEMI) in Quebec]
2016     Institut national d'excellence en sante et en services sociaux (INESSS) [Effect of palivizumab prophylaxis in reducing the complications associated with the respiratory syncytial virus in infants and young children]
2016     Institut national d'excellence en sante et en services sociaux (INESSS) [Evidence brief on the measures related to the reimbursement of blood glucose test strips]
2016     Institut national d'excellence en sante et en services sociaux (INESSS) [Feasibility and appropriateness of implementing satellite radiotherapy centres equipped with a single linear accelerator]
2016     Institut national d'excellence en sante et en services sociaux (INESSS) [Colon cancer investigation, treatment and follow-up algorithm (update)]
2016     Institut national d'excellence en sante et en services sociaux (INESSS) [Rectal cancer investigation, treatment and follow-up algorithm]
2016     Institut national d'excellence en sante et en services sociaux (INESSS) [Optimal long-term use of proton pump inhibitors]
2016     Institut national d'excellence en sante et en services sociaux (INESSS) [Extracorporeal photopheresis: main indications and implementation parameters]
2016     Institut national d'excellence en sante et en services sociaux (INESSS) [Guides for the pharmacological treatment of STBBIs]
2016     Institut national d'excellence en sante et en services sociaux (INESSS) [Impact evaluation of optimal use guidelines implementation for self-monitoring of blood glucose by adult patients with type 2 diabetes and not using insulin]
2016     Institut national d'excellence en sante et en services sociaux (INESSS) [Models for providing care and services to patients who have concurrent mental health and substance use disorders]
2016     Health Quality Ontario (HQO) Transcatheter aortic valve implantation for treatment of aortic valve stenosis: OHTAC recommendation
2016     Health Quality Ontario (HQO) Levonorgestrel-releasing intrauterine system (52 mg) for idiopathic heavy menstrual bleeding: OHTAC Recommendation
2016     Health Quality Ontario (HQO) Magnetic resonance imaging as an adjunct to mammography for breast cancer screening in women at less than high risk for breast cancer: OHTAC recommendation
2016     Health Quality Ontario (HQO) Magnetic resonance imaging as an adjunct to mammography for breast cancer screening in women at less than high risk for breast cancer: a health technology assessment
2016     Health Quality Ontario (HQO) Transcatheter aortic valve implantation for treatment of aortic valve stenosis: a health technology assessment
2016     Health Quality Ontario (HQO) Levonorgestrel-releasing intrauterine sSystem (52 mg) for idiopathic heavy menstrual bleeding: a health technology assessment
2016     Institute of Health Economics (IHE) Hysteroscopic tubal sterilization (using the Essure® system) – an update
2016     Institute of Health Economics (IHE) Endovenous thermal ablation interventions for symptomatic varicose veins of the legs – an update
2016     Institute of Health Economics (IHE) Newborn blood spot screening for galactosemia, tyrosiemia type I, homocystinuria, sickle cell anemia, sickle cell/beta-thalassemia, sickle cell/hemoglobin C disease and severe combined immunodeficiency
2016     Health Quality Ontario (HQO) Fecal microbiota therapy for clostridium difficile infection: OHTAC recommendation
2016     Health Quality Ontario (HQO) Ultrasound as an adjunct to mammography for breast cancer screening: OHTAC recommendation
2016     Health Quality Ontario (HQO) Retinal prosthesis system for advanced retinitis pigmentosa: OHTAC recommendation
2016     Health Quality Ontario (HQO) Composite tissue transplant of hand or arm: OHTAC recommendation
2016     Health Quality Ontario (HQO) Fecal microbiota therapy for clostridium difficile infection: a health technology assessment
2016     Health Quality Ontario (HQO) Women's experiences of inaccurate breast cancer screening results: a systematic review and qualitative meta-synthesis
2016     Health Quality Ontario (HQO) Ultrasound as an adjunct to mammography for breast cancer screening: a health technology assessment
2016     Health Quality Ontario (HQO) Retinal prosthesis system for advanced retinitis pigmentosa: a health technology assessment
2016     Health Quality Ontario (HQO) Composite tissue transplant of hand or arm: a health technology assessment
2016     Health Quality Ontario (HQO) Composite tissue transplant of hand or arm: a health technology assessment
2016     HTA Unit, University of Calgary Pineal gland cysts: an evidence synthesis summary
2016     HTA Unit, University of Calgary Pineal gland cysts: an evidence synthesis
2016     HTA Unit, University of Calgary Laser interstitial thermal therapy for treating intracranial lesions and epilepsy: a health technology assessment and policy analysis
2016     Health Quality Ontario (HQO) Interventions to improve access to primary care for people who are homeless: a systematic review
2016     Health Quality Ontario (HQO) Vertebral augmentation involving vertebroplasty or kyphoplasty for cancer-related vertebral compression fractures: an economic analysis
2016     Health Quality Ontario (HQO) Vertebral augmentation involving vertebroplasty or kyphoplasty for cancer-related vertebral compression fractures: a systematic review
2016     Health Quality Ontario (HQO) Skin testing for allergic rhinitis: a health technology assessment
2016     Health Quality Ontario (HQO) Vertebral augmentation involving vertebroplasty or kyphoplasty for cancer-related vertebral compression fractures: OHTAC recommendation
2016     Health Quality Ontario (HQO) Skin testing for allergic rhinitis: OHTAC recommendation
2016     Institut national d'excellence en sante et en services sociaux (INESSS) [Tonsil surgery: comparison of intracapsular dissections and extracapsular dissections and dentification of children at risk for hemorrhage]
2016     Institut national d'excellence en sante et en services sociaux (INESSS) [Use of the Oncotype DX® test for therapeutic decision-making in the context of treating invasive breast cancer]
2016     Institut national d'excellence en sante et en services sociaux (INESSS) [Localized prostate cancer: effectiveness and safety of treatment options]
2016     Institut national d'excellence en sante et en services sociaux (INESSS) [Levels of care: norms and quality standards]
2016     Technology Assessment at SickKids (TASK) A microcosting and cost-consequence analysis of genomic testing strategies in autism spectrum disorder
2016     Health Quality Ontario (HQO) Minimal residual disease evaluation in childhood acute lymphoblastic leukemia: OHTAC recommendation
2016     Health Quality Ontario (HQO) Repetitive transcranial magnetic stimulation for treatment-resistant depression: OHTAC recommendation
2016     Health Quality Ontario (HQO) Mechanical thrombectomy for patients with acute ischemic stroke: OHTAC recommendation
2016     Health Quality Ontario (HQO) Left ventricular assist devices for destination therapy: OHTAC recommendation
2016     Health Quality Ontario (HQO) Intrathecal drug delivery systems for cancer pain and noncancer pain: OHTAC recommendation
2016     Health Quality Ontario (HQO) Minimal residual disease evaluation in childhood acute lymphoblastic leukemia: an economic analysis
2016     Health Quality Ontario (HQO) Minimal residual disease evaluation in childhood acute lymphoblastic leukemia: a clinical evidence review
2016     Health Quality Ontario (HQO) Repetitive transcranial magnetic stimulation for treatment-resistant depression: an economic analysis
2016     Health Quality Ontario (HQO) Repetitive transcranial magnetic stimulation for treatment- resistant depression: a systematic review and meta-analysis of randomized controlled trials
2016     Health Quality Ontario (HQO) Mechanical thrombectomy in patients with acute ischemic stroke: a health technology assessment
2016     Health Quality Ontario (HQO) Left ventricular assist devices for destination therapy: a health technology assessment
2016     Health Quality Ontario (HQO) Intrathecal drug delivery systems for noncancer pain: a health technology assessment
2016     Health Quality Ontario (HQO) Intrathecal drug delivery systems for cancer pain: a health technology assessment
2016     Technology Assessment at SickKids (TASK) Will the growth spurt continue? Trends in child health. Economic evaluation: 1980 to 2013
2015     Canadian Agency for Drugs and Technologies in Health (CADTH) Long-term use of acamprosate calcium for alcoholism: a review of the clinical effectiveness, safety, and guidelines
2015     Canadian Agency for Drugs and Technologies in Health (CADTH) Public health interventions to reduce the secondary spread of measles
2015     Technology Assessment Unit of the McGill University Health Centre (MUHC) Single-dose intraoperative radiotherapy using Intrabeam® for early-stage breast cancer: an update
2015     Institute of Health Economics (IHE) A systematic review of the measurement properties of self-report instruments that assess presenteeism
2015     Technology Assessment at SickKids (TASK) Systematic review of the cost-effectiveness of influenza immunization programs: a Canadian perspective
2015     Health Quality Ontario (HQO) Paclitaxel drug-eluting stents in peripheral arterial disease: a health technology assessment
2015     Health Quality Ontario (HQO) Paclitaxel drug-eluting stents in peripheral arterial disease: OHTAC recommendation
2015     Canadian Agency for Drugs and Technologies in Health (CADTH) Stool antigen tests for helicobacter pylori infection: a review of clinical and cost-effectiveness and guidelines
2015     Canadian Agency for Drugs and Technologies in Health (CADTH) Protein testing in patients with multiple myeloma: a review of clinical effectiveness and guidelines
2015     Canadian Agency for Drugs and Technologies in Health (CADTH) Transoral robotic surgery: a review of clinical and cost-effectiveness
2015     Canadian Agency for Drugs and Technologies in Health (CADTH) Immediate osseointegrated implants for cancer patients: a review of clinical and cost-effectiveness
2015     Canadian Agency for Drugs and Technologies in Health (CADTH) Electroconvulsive therapy performed outside of surgical suites: a review of the clinical effectiveness, safety, and guidelines
2015     Canadian Agency for Drugs and Technologies in Health (CADTH) Telehealth services for the treatment of psychiatric issues: clinical effectiveness, safety, and guidelines
2015     Canadian Agency for Drugs and Technologies in Health (CADTH) Vitamin D testing in the general population: a review of the clinical and cost-effectiveness and guidelines
2015     Canadian Agency for Drugs and Technologies in Health (CADTH) Holkira (ombitasvir/paritaprevir/ ritonavir with dasabuvir) and Harvoni (ledipasvir/sofosbuvir) for chronic hepatitis C: a review of the clinical evidence
2015     Canadian Agency for Drugs and Technologies in Health (CADTH) Excimer laser and stenting in patients with distal peripheral arterial disease: a review of the clinical effectiveness, safety, and guidelines
2015     Canadian Agency for Drugs and Technologies in Health (CADTH) Rituximab for granulomatosis with polyangiitis or microscopic polyangiitis: a review of the clinical and cost-effectiveness
2015     Canadian Agency for Drugs and Technologies in Health (CADTH) Perceval S sutureless valve for aortic valve replacement: a review of the clinical effectiveness, safety, and cost-effectiveness
2015     Institut national d'excellence en sante et en services sociaux (INESSS) [Bendamustine for the treatment of follicular lymphoma]
2015     Institut national d'excellence en sante et en services sociaux (INESSS) [Detection and diagnosis of Alzheimer's disease and other neurocognitive disorders]
2015     Institut national d'excellence en sante et en services sociaux (INESSS) [Gene sequencing of tumours: clinical validity and utility of molecular profiles obtained by next-generation sequencing (NGS) technologies]
2015     Health Quality Ontario (HQO) Transient elastography and controlled attenuation parameter for diagnosing liver fibrosis and steatosis in Ontario: an economic analysis
2015     Health Quality Ontario (HQO) Transient elastography for assessment of liver fibrosis and steatosis: OHTAC recommendation
2015     Health Quality Ontario (HQO) Transient elastography for assessment of liver fibrosis and steatosis: an evidence-based analysis
2015     Health Quality Ontario (HQO) Patient perspectives on quality of life with controlled type 1 diabetes mellitus: a systematic review and qualitative meta-synthesis
2015     Health Quality Ontario (HQO) Pancreas islet transplantation for patients with type 1 diabetes mellitus: OHTAC recommendation
2015     Health Quality Ontario (HQO) Pancreas islet transplantation for patients with type 1 diabetes mellitus: a clinical evidence review
2015     Institute for Clinical Evaluative Sciences (ICES) Brain disorders in Ontario: prevalence, incidence and costs from health administrative data
2015     Technology Assessment at SickKids (TASK) Thiopurine S-methyltransferase testing for averting drug toxicity in patients receiving thiopurines: A meta-analysis of diagnostic test accuracy
2015     Technology Assessment at SickKids (TASK) Thiopurine S-methyltransferase testing for averting drug toxicity in patients receiving thiopurines: A systematic review and quality appraisal
2015     Institut national d'excellence en sante et en services sociaux (INESSS) [Investigation, treatment and monitoring algorithms for prostate cancer]
2015     Institut national d'excellence en sante et en services sociaux (INESSS) [Review process of matricial requirements for acute care facilities in the Quebec traumatology network]
2015     Institut national d'excellence en sante et en services sociaux (INESSS) [Levels of medical intervention -- levels of care]